Filed: 2/1/2023ACC: 0001104659-23-009328
📋 What this filing means
NORTHPOND VENTURES, LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $184.35M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$184.35M
Total AUM (reported)
28.10M
Total Shares
Allocation by class
COM$184.35M100.0%
Portfolio Concentration
Top 3$169.07M91.7%
4–10$15.28M8.3%
Top 3 weight
91.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 28.10M
Sole
Full voting authority
28.10M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
DICE THERAPEUTICS INC
SOLEShares3.29M
TypeSH
Market value$102.74M
55.73%
Sole
3.29M
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares4.21M
TypeSH
Market value$52.68M
28.58%
Sole
4.21M
Shared
0.00
None
0.00
ISOPLEXIS CORP
SOLEShares8.81M
TypeSH
Market value$13.65M
7.41%
Sole
8.81M
Shared
0.00
None
0.00
TELESIS BIO INC
SOLEShares9.84M
TypeSH
Market value$11.81M
6.41%
Sole
9.84M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$3.46M
1.88%
Sole
1.94M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DICE THERAPEUTICS INCSOLE | COM | 3.29M | SH | $102.74M 55.73% | 3.29M | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 4.21M | SH | $52.68M 28.58% | 4.21M | 0.00 | 0.00 |
ISOPLEXIS CORPSOLE | COM | 8.81M | SH | $13.65M 7.41% | 8.81M | 0.00 | 0.00 |
TELESIS BIO INCSOLE | COM | 9.84M | SH | $11.81M 6.41% | 9.84M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 1.94M | SH | $3.46M 1.88% | 1.94M | 0.00 | 0.00 |